Suppr超能文献

血管外科学会血管质量改进计划中主动脉腔内介入术后的卒中发生率

Stroke rate after endovascular aortic interventions in the Society for Vascular Surgery Vascular Quality Initiative.

作者信息

Swerdlow Nicholas J, Liang Patric, Li Chun, Dansey Kirsten, O'Donnell Thomas F X, de Guerre Livia E V M, Varkevisser Rens R B, Patel Virendra I, Wang Grace J, Schermerhorn Marc L

机构信息

Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Boston, Mass.

Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Boston, Mass; Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, Mass.

出版信息

J Vasc Surg. 2020 Nov;72(5):1593-1601. doi: 10.1016/j.jvs.2020.02.015. Epub 2020 Apr 2.

Abstract

OBJECTIVE

The stroke rate after endovascular aneurysm repair (EVAR), particularly complex EVAR such as fenestrated EVAR (FEVAR) and chimney EVAR (chEVAR), is not well defined. Whereas stroke is a well-established risk of thoracic endovascular aortic repair (TEVAR), the impact of procedural characteristics on stroke remains unclear. Therefore, we characterized the risk of stroke after endovascular aortic interventions in the Vascular Quality Initiative database and identified procedural characteristics associated with stroke.

METHODS

We performed a retrospective cohort study of patients undergoing infrarenal EVAR, complex EVAR, and TEVAR within the Vascular Quality Initiative between 2011 and 2019. Complex EVAR included FEVAR (with either a Food and Drug Administration-approved custom-manufactured device or physician-modified endovascular graft) and chEVAR. We excluded emergent procedures. The primary outcome was in-hospital stroke. We used multivariable logistic regression to identify procedural characteristics associated with stroke.

RESULTS

We identified 41,540 EVARs, 1371 complex EVARs, and 4600 TEVARs. The in-hospital stroke rate was 0.1% after EVAR, 0.9% after complex EVAR, and 2.9% after TEVAR. In patients undergoing EVAR, aneurysm diameter >6.5 mm (odds ratio [OR], 1.7; 95% confidence interval [CI], 1.1-2.7; P = .03) and use of a proximal extension cuff (OR, 3.3; 95% CI, 1.4-7.9; P < .01) were independently associated with stroke. Among complex EVARs, stroke rate was 0.7% after FEVAR with a custom-manufactured device, 0.4% after FEVAR with a physician-modified endovascular graft, and 2.1% after chEVAR (P = .08). In multivariable analysis, arm access was associated with 8.4-fold higher odds of stroke (95% CI, 1.7-41; P < .01). Whereas chEVAR was associated with higher odds of stroke in crude analysis, this association did not persist after adjustment for arm access (OR, 1.0; 95% CI, 0.2-4.4; P = .99). In patients undergoing TEVAR, more proximal landing zones were associated with higher risk of stroke compared with zone 4/5 (zone 3: OR, 2.0 [95% CI, 0.9-4.2]; zone 2: OR, 3.8 [95% CI, 1.8-8.2]; zone 0/1: OR, 6.3 [95% CI, 2.8-14]). In terms of procedural characteristics, any involvement of the left subclavian artery was associated with stroke (bypass: OR, 2.5 [95% CI, 1.5-4.0]; stent: OR, 2.7 [95% CI, 0.9-8.5]; covered or occluded: OR, 2.5 [95% CI, 1.5-4.1]).

CONCLUSIONS

Stroke, although rare after elective EVAR, is substantially more common after complex EVAR and TEVAR. Increasing procedural complexity in complex EVAR and TEVAR is associated with a higher stroke rate, a risk that should be factored into clinical decision-making. The strong association between stroke and upper extremity access during complex EVAR is alarming and warrants further study.

摘要

目的

血管内动脉瘤修复术(EVAR)后的卒中发生率,尤其是复杂的EVAR,如开窗EVAR(FEVAR)和烟囱式EVAR(chEVAR),目前尚无明确界定。虽然卒中是胸主动脉腔内修复术(TEVAR)公认的风险,但手术特征对卒中的影响仍不明确。因此,我们在血管质量改进计划数据库中对主动脉腔内干预术后的卒中风险进行了特征分析,并确定了与卒中相关的手术特征。

方法

我们对2011年至2019年期间在血管质量改进计划内接受肾下EVAR、复杂EVAR和TEVAR的患者进行了一项回顾性队列研究。复杂EVAR包括FEVAR(使用美国食品药品监督管理局批准的定制设备或医生改良的血管内移植物)和chEVAR。我们排除了急诊手术。主要结局是住院期间发生的卒中。我们使用多变量逻辑回归来确定与卒中相关的手术特征。

结果

我们确定了41540例EVAR、1371例复杂EVAR和4600例TEVAR。EVAR术后住院卒中发生率为0.1%,复杂EVAR术后为0.9%,TEVAR术后为2.9%。在接受EVAR的患者中,动脉瘤直径>6.5 mm(比值比[OR],1.7;95%置信区间[CI],1.1 - 2.7;P = 0.03)和使用近端延长袖套(OR,3.3;95% CI,1.4 - 7.9;P < 0.01)与卒中独立相关。在复杂EVAR中,使用定制设备的FEVAR术后卒中发生率为0.7%,使用医生改良血管内移植物的FEVAR术后为0.4%,chEVAR术后为2.1%(P = 0.08)。在多变量分析中,经上肢入路与卒中几率高8.4倍相关(95% CI,1.7 - 41;P < 0.01)。虽然在粗分析中chEVAR与卒中几率较高相关,但在调整经上肢入路后,这种关联不再存在(OR,1.0;95% CI,0.2 - 4.4;P = 0.99)。在接受TEVAR的患者中,与4/5区相比,更高的近端锚定区与卒中风险更高相关(3区:OR,2.0 [95% CI,0.9 - 4.2];2区:OR,3.8 [95% CI,1.8 - 8.2];0/1区:OR,6.3 [95% CI,2.8 - 14])。在手术特征方面,左锁骨下动脉的任何累及都与卒中相关(旁路:OR,2.5 [95% CI,1.5 - 4.0];支架:OR,2.7 [95% CI,0.9 - 8.5];覆盖或闭塞:OR,2.5 [95% CI,1.5 - 4.1])。

结论

卒中在择期EVAR后虽然罕见,但在复杂EVAR和TEVAR后则更为常见。复杂EVAR和TEVAR中手术复杂性的增加与更高的卒中发生率相关,这一风险应纳入临床决策考量。复杂EVAR期间卒中与上肢入路之间的强关联令人担忧,值得进一步研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验